Press Releases Events & Presentations Event Details AASLD – The Liver Meeting 2022 Nov 4 - Nov 8, 2022 Supporting Materials Poster – ABI-4334 – Preclinical characterization: Accelerates capsid assembly and inhibits cccDNA formation via multiple pathways 513.1 KB Poster – HBV and HDV Entry Inhibitor Program – Preclinical characterization 1.1 MB Late-breaking poster – Interferon Small Molecule Receptor (IFNAR) Agonist Program – Preclinical characterization 1 MB Late-breaking poster – Vebicorvir – Interim data from open label Study 204 evaluating vebicorvir, NrtI and AB-729 combination 603.1 KB Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
AASLD – The Liver Meeting 2022 Nov 4 - Nov 8, 2022 Supporting Materials Poster – ABI-4334 – Preclinical characterization: Accelerates capsid assembly and inhibits cccDNA formation via multiple pathways 513.1 KB Poster – HBV and HDV Entry Inhibitor Program – Preclinical characterization 1.1 MB Late-breaking poster – Interferon Small Molecule Receptor (IFNAR) Agonist Program – Preclinical characterization 1 MB Late-breaking poster – Vebicorvir – Interim data from open label Study 204 evaluating vebicorvir, NrtI and AB-729 combination 603.1 KB
Poster – ABI-4334 – Preclinical characterization: Accelerates capsid assembly and inhibits cccDNA formation via multiple pathways 513.1 KB
Late-breaking poster – Interferon Small Molecule Receptor (IFNAR) Agonist Program – Preclinical characterization 1 MB
Late-breaking poster – Vebicorvir – Interim data from open label Study 204 evaluating vebicorvir, NrtI and AB-729 combination 603.1 KB
